For many years, healthcare institutions have been focused on different ways to decrease HAIs, as federal reimbursement initiatives loomed. So, what does this report card tell us? We've come a long way, baby, but there's still a ways to go.
If I'm predisposed to being fond of infectious disease physicians, it's because I believe they offer insight beyond that of a general practitioner. This is not to say that a long-term care facility's medical director can't handle a flu outbreak. But it is acknowledging that long-term care staff handles large caseloads with complex patients, and that more facilities should embrace partnerships with an ID physician.
A potential Clostridium difficile vaccine performed well in initial tests and now has moved into a large Phase III trial, researchers announced today. The news from developer Sanofi Pasteur raises hopes that the antibiotic-resistant infection can be prevented in long-term care facilities and other settings where it has become a deadly scourge.
Fecal transplants to cure Clostridium difficile could become more common, following a trial that successfully used frozen stool specimens, according to researchers at Massachusetts General Hospital.
One of my former colleagues, who had moved to the healthcare sector from television, shared with me the story of how she began her new job and was told, "Oh, yeah, you can figure out the budget, right?" Administrators with limited budgeting experience might hesitate to make big investments, but when it comes to hand hygiene, spending a little more today could lead to big savings down the line.
It is tempting to run to my internist and beg for an antibiotic to stem what could be a sinus infection, but is more likely, much like the polar vortex, a cold that won't go away. I was reminded of the need to hold back by a new study in JAMA Internal Medicine that reminds us that nearly half the antibiotic prescriptions given for respiratory infections are incorrect, as the majority of the diseases in question are viruses.
New research challenges assumptions about how Clostridium difficile is transmitted.
Pills created from fecal matter are the latest breakthrough in treating Clostridium difficile, according to a doctor in Canada who says he has cured about 30 people this way.
High and low dosages of a popular antibiotic are equally good at combating Clostridium difficile infections, according to a new study.
Sanofi Pasteur's vaccine division has started a Phase III clinical trial to evaluate the safety and efficacy of a vaccine for Clostridium difficile.
A new study contradicts widely held assumptions about how Clostridium difficile infection occurs, which may lead long-term care providers to step up control measures.
People who take proton-pump inhibitor medications are at increased risk for developing a Clostridium difficile infection, according to a recently published study that supports previous findings.
High and low dosages of a popular antibiotic offer little difference in the outcomes of Clostridium difficile infections, according to a new study.
The bacterial infection Clostridium difficile is most effectively diagnosed through a method called cytotoxin assay, a new study has found.
Probiotics are not effective in preventing diarrhea associated with Clostridium difficile, according to a large study that calls into question previous findings.
Probiotics are not effective in preventing diarrhea associated with Clostridium difficile infection, according to a large study that calls into question previous findings. The findings of the U.K. study are especially significant because its size "dwarfs" previous studies, wrote Nick Daneman, M.D., FRCPC, of the University of Toronto.
Back in June, I declared medication to be the long-term care topic of the summer. But this week, a different topic has stolen the spotlight: Clostridium difficile.
Antibiotics often aren't enough to combat Clostridium difficile. But when combined with probiotics, or "good" bacteria, the results are striking. The treatment combo lessens the likelihood of C. diff symptoms by 64%, according to a recent study.
Individuals with treatment-resistant Clostridium difficile can undergo fecal transplants after giving informed consent, the Food and Drug Administration recently announced. This is a victory for providers, who pushed back after the FDA recently announced it would tighten regulations around the transplants.
Clostridium difficile poses a serious public health threat and potential treatments should be fast-tracked, the Food and Drug Administration stated in a newly proposed regulation.
Every few days I read the Food and Drug Administration (FDA) news to see if there is anything relevant to eldercare that I should be aware of. Recently, I came across an extremely eye-opening item.
Long-term care facilities dealing with an outbreak of Clostridium difficile have a good chance of reducing symptoms of the infection by administering probiotics, according to a recently released comprehensive review of randomized trials.
Depressed or lonely people are at increased risk of Clostridium difficile infection, according to research in BMC Medicine.
The Food and Drug Administration is moving to tighten regulations around fecal transplants, which research has shown to be an effective treatment for Clostridium difficile infection.
People who are depressed or lonely are at increased risk of Clostridium difficile infection, according to recently published research.
Long-term care providers might want to pay special attention to residents with certain recently identified risk factors for Clostridium difficile. These factors are chronic dialysis, recent hospitalization and use of corticosteroids such as prednisone.
Stomach acid is often treated with medications such as Pepcid, but that could put long-term care residents or hospitalized patients at risk for Clostridium difficile, according to a new analysis.
Preventing the spread of MRSA, CRE and other hospital-acquired infections(HAI's) is quickly becoming a top priority in skilled nursing and long-term care facilities. Yet we often overlook disinfecting procedures on our vital signs monitoring equipment.
People with end-stage renal disease (ESRD) have a significantly elevated risk of dying from Clostridium difficile infection, according to a recent study.
Taking antihistamines such as Tagamet, Pepcid and Zantac increases the risk that people in healthcare settings will be infected with Clostridium difficile, according to a recently published study.